Public Profile

FinVector

FinVector, officially known as FinVector Vision, is a leading player in the biotechnology sector, headquartered in Finland (FI). Established in 2010, the company has made significant strides in the development of innovative gene therapy solutions, focusing on rare diseases and genetic disorders. With a strong operational presence across Europe and North America, FinVector is renowned for its cutting-edge viral vector technology, which sets it apart in the competitive landscape. The company’s core offerings include advanced AAV (adeno-associated virus) vectors, designed to enhance the delivery of therapeutic genes. FinVector has achieved notable milestones, including strategic partnerships with major pharmaceutical firms, solidifying its position as a trusted provider in the gene therapy market. With a commitment to scientific excellence and patient-centric solutions, FinVector continues to drive advancements in the field of biotechnology.

DitchCarbon Score

How does FinVector's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

6

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

FinVector's score of 6 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.

82%

FinVector's reported carbon emissions

FinVector, headquartered in Finland (FI), currently does not have available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed emissions data, it is essential for FinVector to establish clear climate commitments and reduction initiatives to align with industry standards and expectations for sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. FinVector's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. FinVector is headquartered in FI, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

FinVector is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Mattole Valley Naturals

US
Health Services
Updated 10 days ago

Vebego Cleaning Services B.V.

NL
Health Services
Updated 3 days ago

Certified Nutraceuticals

US
Health Services
Updated 10 days ago

AcroMetrix LLC

US
Health Services
Updated 4 days ago
CDP

Saifu Chemical Development Co. Ltd.

CN
Health Services
Updated 7 days ago

American HomePatient, Inc.

US
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers